DarioHealth Corp. Amortization of Intangible Assets
DarioHealth Corp. (DRIO) reported Amortization of Intangible Assets of $468.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-11
- DarioHealth Corp. amortization of intangible assets for the quarter ending 2026-06-30 was $468.00K, a 35.18% decline year-over-year.
- DarioHealth Corp. amortization of intangible assets for the quarter ending 2026-03-31 was $463.00K, a 60.15% decline year-over-year.
- DarioHealth Corp. amortization of intangible assets for the quarter ending 2025-12-31 was $474.00K, a 70.02% decline year-over-year.
- DarioHealth Corp. amortization of intangible assets for the quarter ending 2025-09-30 was $473.00K, a 76.39% decline year-over-year.
- DarioHealth Corp. amortization of intangible assets for fiscal 2025 was $2.83M, a 53.59% decline from fiscal 2024.
- DarioHealth Corp. amortization of intangible assets for fiscal 2024 was $6.10M, a 35.20% increase from fiscal 2023.
- DarioHealth Corp. amortization of intangible assets for fiscal 2023 was $4.51M, a 3.46% increase from fiscal 2022.
- DarioHealth Corp. amortization of intangible assets for fiscal 2022 was $4.36M, a 4.46% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $468.00K 10-Q · filed 2026-08-11 | $931.00K 10-Q · filed 2026-08-11 | $1.41M derived: sum of 3 quarters · filed 2026-08-11 | $1.88M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $463.00K 10-Q · filed 2026-05-13 | $937.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.41M derived: sum of 3 quarters · filed 2026-05-13 | $2.13M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $947.00K derived: sum of 2 quarters · filed 2026-03-19 | $1.67M derived: sum of 3 quarters · filed 2026-08-11 | $2.83M 10-K · filed 2026-03-19 | ||
| 2025-09-30 | $473.00K 10-Q · filed 2025-11-13 | $1.20M derived: sum of 2 quarters · filed 2026-08-11 | $2.36M 10-Q · filed 2025-11-13 | $3.94M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $722.00K 10-Q · filed 2026-08-11 | $1.88M 10-Q · filed 2026-08-11 | $3.46M derived: sum of 3 quarters · filed 2026-08-11 | $5.47M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $1.16M 10-Q · filed 2026-05-13 | $2.74M derived: sum of 2 quarters · filed 2026-05-13 | $4.75M derived: sum of 3 quarters · filed 2026-05-13 | $6.05M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $3.58M derived: sum of 2 quarters · filed 2026-03-19 | $4.88M derived: sum of 3 quarters · filed 2026-03-19 | $6.10M 10-K · filed 2026-03-19 | ||
| 2024-09-30 | $2.00M 10-Q · filed 2025-11-13 | $3.30M derived: sum of 2 quarters · filed 2025-11-13 | $4.52M 10-Q · filed 2025-11-13 | $5.66M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $1.30M 10-Q · filed 2025-08-12 | $2.52M 10-Q · filed 2025-08-12 | $3.65M derived: sum of 3 quarters · filed 2025-08-12 | $4.79M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-14 | $2.35M derived: sum of 2 quarters · filed 2025-05-14 | $3.49M derived: sum of 3 quarters · filed 2025-05-14 | $4.62M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $2.27M derived: sum of 2 quarters · filed 2025-03-10 | $3.40M derived: sum of 3 quarters · filed 2025-03-10 | $4.51M 10-K · filed 2025-03-10 | ||
| 2023-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.26M derived: sum of 2 quarters · filed 2023-11-02 | $3.38M 10-Q · filed 2023-11-02 | $4.51M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2023-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.24M 10-Q · filed 2023-08-10 | $3.38M derived: sum of 3 quarters · filed 2024-03-28 | $4.51M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2023-03-31 | $1.11M 10-Q · filed 2023-05-11 | $2.25M derived: sum of 2 quarters · filed 2024-03-28 | $3.39M derived: sum of 3 quarters · filed 2024-03-28 | $4.51M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.27M derived: sum of 2 quarters · filed 2024-03-28 | $3.40M derived: sum of 3 quarters · filed 2024-03-28 | $4.36M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.26M derived: sum of 2 quarters · filed 2022-11-14 | $3.22M 10-Q · filed 2022-11-14 | $4.02M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2022-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.09M 10-Q · filed 2022-08-15 | $2.88M derived: sum of 3 quarters · filed 2023-03-09 | $5.16M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2022-03-31 | $963.00K 10-Q · filed 2022-05-12 | $1.76M derived: sum of 2 quarters · filed 2023-03-09 | $4.03M derived: sum of 3 quarters · filed 2023-03-09 | $4.76M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-12-31 | $794.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $3.07M derived: sum of 2 quarters · filed 2023-03-09 | $3.80M derived: sum of 3 quarters · filed 2023-03-09 | $4.17M 10-K · filed 2023-03-09 | $3.04M 10-K · filed 2022-03-22 | |
| 2021-09-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.01M derived: sum of 2 quarters · filed 2022-11-14 | $3.38M 10-Q · filed 2022-11-14 | $2.40M 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $731.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.11M 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $375.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |